BHCHX Mutual Fund

BHCHX Mutual Fund

NAV$22.97
See how much of BHCHX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.85%
Dividend Yield (Current)
-
Holdings
41
Inception Date
Apr 30, 2018
Fund Family
Baron Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Unspecified

Performance

YTD+3.81%
1 Year+25.03%
3 Year+5.49%
5 Year+0.95%

Asset Allocation

Stocks: 100.00%
See how much of BHCHX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.9.95%
AZN:LNAstraZeneca PLC5.09%
JNJJohnson & Johnson - Common4.58%
TMOThermo Fisherscientific Inc.4.25%
MTDMettler-Toledo International Inc.3.99%
Top 10 Concentration: 43.86%Report Date: Mar 31, 2026
Download all 41 holdings for BHCHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

BHCHX Mutual Fund Overview

BHCHX Mutual Fund (Baron Health Care Fund Institutional Shares) is managed by Baron Funds. BHCHX expense ratio is 0.85%, holding 41 positions across sectors including Health Care, Real Estate. Inception date: 2018-04-30.

BHCHX performance shows a YTD return of 3.81%. The 1-year return is 25.03% and the 5-year return is 0.95%.

BHCHX top holdings include Eli Lilly & Co. (9.9%), AstraZeneca PLC (5.1%), Johnson & Johnson - Common (4.6%), Thermo Fisherscientific Inc. (4.3%), Mettler-Toledo International Inc. (4.0%). Go to all BHCHX holdings, BHCHX sectors, or BHCHX dividends.

BHCHX can be compared against other funds. Use BHCHX overlap to find shared positions, or BHCHX vs another fund for a side-by-side view. BHCHX alternatives are available via the screener, along with tax-loss harvesting opportunities.